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Everything  is  Illuminated,  Liev  Schreiber’s  2005  direc­
torial debut, is a charming offbeat movie about a young 
man on a self­driven quest in a foreign land. Through his 
journey, he finds connections between past and present 
and between things that initially appear completely un­
related.  Both  the  title  and  the  unifying  theme  of  the 
movie match current trends and advances in molecular 
biology well. Like the character in the film, researchers 
meticulously collect information using newly developed 
high­throughput and high­resolution technologies. And 
as  they  work  to  make  sense  of  these  new  findings, 
unifying  themes  begin  to  emerge.  At  the  recent  Inter­
national Conference on Intelligent Systems for Molecular 
Biology  and  the  associated  Special  Interest  Group 
meeting  on  Alternative  Splicing  in  Boston,  attendees 
were treated to talks covering diverse topics that, when 
taken together, offered a glimpse of the inter  connected­
ness of traditionally separate fields in molecular biology 
and  the  ever­improving  tools  available  to  study  them. 
Here we present a few of the highlights of the meetings.
A unified view of the transcriptome
At the level of the transcriptome, evidence is accumu  lating 
about the physical and regulatory coupling between RNA 
splicing  and  nucleosome  positioning,  histone  modifi­
cations and non­coding RNAs. Nature does not seem to 
follow  the  human­contrived  definitions  that  separate 
biological  processes  or  research  fields,  and  building  a 
unified  model  of  the  transcriptome  requires  combining 
information from different fields. Addressing the question 
of  the  control  of  alternative  RNA  splicing,  Reini  Luco 
(National Cancer Institute, National Institutes of Health, 
Bethesda, USA) described how the trimethy  lation of lysine 
36 on histone H3 (H3K36me3) can change the pattern of 
alternative exon inclusion. By studying alternative exons 
within  the  human  fibroblast  growth  factor  receptor  2 
(FGFR2)  and  several  other  human  genes,  Luco  and 
colleagues found that modulation of the expression levels 
of  the  H3K36  methyltransferase  SETD2  and  the 
H3K36me3­binding  protein  MRG15  affect  the  splicing 
patterns of a set of exons regulated by the protein PTB, an 
RNA­binding  splicing  factor.  They  then  used  high­
throughput RNA sequencing to measure splicing changes 
in cells depleted of SETD2, MRG15 or PTB, and found 
significant overlap between differentially spliced exons in 
all three groups. Luco showed that the splicing changes 
correlated with the strength of the nearby PTB­binding 
sites. Investigating the role that other modifi  cations may 
play  in  splicing,  Luco  presented  preliminary  chromatin 
immunoprecipitation  and  sequencing  (ChIP­seq)  and 
RNA  sequencing  (RNA­seq)  data  on  the  genome­wide 
asso  ciation between dozens of different histone marks and 
alternatively  spliced  exons.  Christian  Muchardt  (CNRS 
Institut Pasteur, Paris, France) described findings suggest­
ing increased H3K9me3 marks near alternative exons in 
the  human  CD44  gene,  and  showed  that  the 
chromodomain­containing  protein  HP1γ,  which  binds 
H3K9me3 marks, can regulate alter  native exon inclusion.
Several  speakers  at  the  AS­SIG  also  presented  data 
showing connections between transcriptional gene silen­
cing by small RNAs and the regulation of RNA splicing. 
In  particular,  Mariano  Alló  (Universidad  de  Buenos 
Aires, Argentina) described work on the ability of small 
RNAs to affect alternative splicing patterns. He showed 
that small interfering RNAs targeted to regions near an 
alternative  exon  in  the  human  fibronectin  1  gene  can 
affect exon inclusion in an Argonaute 1 and 2­dependent 
manner,  and  that  the  effect  also  depended  on  the 
presence of nearby histone marks. A genome­wide scan 
yielded  a  set  of  splicing  events  with  similar  adjacent 
features that could also be regulated by this mechanism, 
suggesting that it may be used more generally in the cell.
John  Rinn  (Broad  Institute,  Cambridge,  USA) 
presented his group’s investigations on the role of large 
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© 2010 BioMed Central Ltdintergenic  non­coding  RNAs  (lincRNAs).  A  genome­
wide screen in mouse identifying potentially non­coding 
loci enriched with transcriptionally active histone modi­
fi  cations led to the discovery of several new lincRNAs. 
Using  a  guilt­by­association  technique  to  ascribe 
potential  functions,  Rinn  and  colleagues  focused  on  a 
lincRNA upstream of the p21 gene that was induced by 
p53,  was  necessary  for  apoptosis,  and  could  act  as  a 
global  repressor  of  gene  expression.  In  regard  to  the 
regulatory  mechanism,  this  lincRNA  was  found  to  be 
bound to a highly conserved region in a specific hetero­
geneous nuclear ribonucleoprotein.
In a highlight talk, Christopher Burge (Massachusetts 
Institute of Technology, Cambridge, USA) set a target for 
the alternative splicing field to further develop compu  ta­
tional tools that can combine data from high­resolution, 
high­throughput technologies to build predictive models 
for  the  transcriptome,  and  he  described  new  tech  no­
logical  advances  that  will  facilitate  these  predictive 
models. Earlier, at the AS­SIG, YB presented work by the 
authors  of  this  report  on  the  tissue­regulated  splicing 
code, which was mentioned by Burge during his talk. He 
focused on a new technology currently being developed 
in his lab that uses Illumina high­throughput sequencing 
technology  to  quantitatively  assess  the  DNA­binding 
affinity of transcription factors. Burge discussed current 
efforts to extend this approach for RNA­binding proteins 
and  illustrated  its  usefulness  by  describing  insights 
gained into the binding affinity of the yeast transcription 
factor GCN4.
Making sense of high-throughput data
As  experiments  using  the  new  high­throughput  tech­
nologies  generate  data  at  an  increasingly  rapid  rate, 
computational biologists are developing algorithms that 
can  accurately  extract  information  from  these  data. 
Specifically,  the  analysis  of  sequencing  data  still  poses 
many challenges. Xiaoyu Chen (University of Washing­
ton, Seattle, USA) described a dynamic Bayesian network 
model aimed at identifying transcription­factor­binding 
sites  in  yeast  DNA  from  genomic  footprinting  experi­
ments involving DNase I digestion of chromatin followed 
by high­throughput sequencing. Jared Simpson (Wellcome 
Trust Sanger Institute, Hinxton, UK) described work to 
construct a tool that can assemble a genome from short 
reads and can handle genomes up to several gigabases in 
size, such as that of human. Unlike current commonly 
used algorithms that utilize de Bruijn graphs, the new 
method efficiently constructs a string graph from a set of 
reads,  an  approach  particularly  well  suited  for  the 
assembly of mixed­length read data. Simpson described 
hurdles still to be overcome in constructing a genome 
assembler, such as the need to accommodate for possible 
sequencing errors in the short reads.
Many high­throughput technologies produce data that 
are  difficult  to  interpret  directly  with  the  human  eye. 
Consequently, another area that received much attention 
was the visualization of biological datasets. Gary Bader 
(University of Toronto, Ontario, Canada) presented new 
plug­ins for the Cytoscape software commonly used for 
visualizing molecular interaction networks that will help 
perform  enrichment  analysis  of  sets  of  nodes  in  large 
networks.  Lincoln  Stein  (Ontario  Institute  for  Cancer 
Research,  Toronto,  Canada)  presented  new  features  of 
Reactome,  a  manually  curated  database  for  biological 
pathways, with a web interface that lets users perform 
queries  and  searches.  He  also  described  a  Reactome 
standalone plug­in for Cytoscape that enables users to 
integrate  and  visualize  Reactome  data  with  data  from 
other sources.
There’s plenty of room at the bottom
The  study  of  molecular  biology  at  increasingly  fine 
resolution was another popular theme. Jonathan Widom 
(Northwestern University, Evanston, USA) described the 
confirmation of previous studies of nucleosome­binding 
preferences and locations in yeast, but with new data at 
single­nucleotide  resolution.  Eran  Segal  (Weizmann 
Institute, Rehovot, Israel) described an experimental set­
up to investigate, at much higher resolution than before, 
the regulatory effect of poly(A) tracts near transcription 
factor binding sites in yeast promoter regions. Revisiting 
a model suggested by Iyer and Struhl in 1995, in which 
poly(A) tracts serve to deplete promoters of repressive 
nucleosomes, Segal and his colleagues can now quantify 
the effect on gene expression of parameters such as the 
poly(A) tract length, the proportion of adenine nucleo­
tides,  and  the  distance  from  the  transcription  factor 
binding  sites.  They  showed  that  there  is  a  trade­off  
between the length of the poly(A) tract and the propor­
tion of adenine nucleotides in it, and that the influence of 
the tract falls steadily with distance from the transcrip­
tion  factor  binding  site,  until  a  distance  of  200  bases, 
where a local peak is reached. The location of the peak 
determined experimentally in this way does not, however, 
match  well  with  current  computational  models.  An 
interesting  question  still  to  be  answered  is  whether 
poly(A) tract boundaries serve to fine­tune the expression 
levels of adjacent genes.
Jean Beggs (University of Edinburgh, UK) described the 
use of RiboSys reporters to enable her group to monitor 
cell number, DNA yield, RNA yield, reverse transcription 
efficiency,  quantitative  PCR  efficiency  and  RNA  copy 
number per cell (using single­molecule FISH) in yeast at 
30­second  intervals.  Using  this  system,  she  and  her 
colleagues identified a 30­second pause in the progress of 
the RNA polymerase II (Pol II) complex when splicing is 
occurring in yeast RNAs. They have also identified what 
Barash and Wang Genome Biology 2010, 11:307 
http://genomebiology.com/2010/11/8/307
Page 2 of 3appears to be a novel surveillance mechanism, in which 
phosphorylation of the Pol II complex at Ser5 is used to 
first pause it and then at Ser2 to resume its progress, and 
involving  several  proteins  such  as  Ioc2  and  Ioc4 
(members of the Isw1 chromatin­remodeling complex). 
As  Beggs  pointed  out,  one  could  only  observe  this 
mechanism with a high­resolution system such as theirs, 
and  only  when  the  yeast  cell  population  was  well 
synchronized.
Computational approaches for studying disease
Opening  the  ISMB  main  conference,  Steven  Brenner 
(University of California, Berkeley, USA), told an inspir­
ing story about a lab member whose successful treatment 
for  lung  cancer  was  a  result  of  a  better  molecular 
understanding of a specific cancer mutation she carried. 
The  interest  in  using  computational  biology  to  better 
understand  the  etiology  and  pathology  of  cancer  and 
other diseases was exemplified by the fact that more than 
half of the timeslots at this year’s conference featured at 
least one talk on studying human disease with compu­
tational methods. In a prize­winning talk, Peter Van Loo 
(University of Leuven, Belgium) presented an algorithm 
called ASCAT (Allele­Specific Copy number Analysis of 
Tumors),  which  takes  signal  intensities  from  whole­
genome  single­nucleotide  polymorphism  array  data  to 
estimate the proportion of tumor cells and tumor ploidy 
in  a  heterogeneous  sample.  On  a  genome­wide  scale, 
ASCAT  can  then  identify  cancer­associated  copy­
number changes for individual loci.
In  relation  to  pharmacogenomics,  Rachel  Karchin 
(Johns  Hopkins  University,  Baltimore,  USA)  described 
computational  approaches  for  distinguishing  driver 
muta  tions, which can identify genes that may be promis­
ing drug targets, from passenger mutations in the genetic 
landscape of a tumor. She discussed a tool called CHASM 
(Cancer­specific High­throughput Annotation of Somatic 
Mutations) developed in her lab, which uses a machine­
learning  approach  to  classify  missense  mutations  into 
these  two  categories  on  the  basis  of  properties  of  the 
mutated  amino  acids  that  may  affect  the  translated 
protein.  David  Altshuler  (Harvard  Medical  School, 
Cambridge, USA) supplied a word of caution during his 
keynote talk about the value of disease prediction. Giving 
the  example  of  the  detection  of  prostate  cancer  using 
prostate­specific  antigen,  Altshuler  emphasized  that 
being able to predict outcomes does not automatically 
translate to being able to help patients. In this case, the 
corresponding  treatment  did  not  increase  the  patients’ 
life  expectancy,  but  did  saddle  many  individuals  with 
debilitating side effects.
The  themes  reviewed  here  reflect  how  the  field  of 
computational biology is constantly shifting, adapting to 
the  new  high­resolution  and  high­throughput  tech­
nologies that are being developed, as well as to the new 
scientific  questions  these  technologies  allow  us  to  ask. 
Data  processing  and  visualization  can  therefore  be 
expected as central themes at ISMB conferences in the 
future, but we should also expect to see work exploring 
the unified view of the transcriptome and its complexity, 
with connections to focused disease studies.
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